Get the Stockscreener App
0.0695
6.92%
0.0045
After Hours:
.07
0.0005
+0.72%
Hepion Pharmaceuticals Inc stock is traded at $0.0695, with a volume of 7,705.
It is up +6.92% in the last 24 hours and up +25.91% over the past month.
See More
Previous Close:
$0.065
Open:
$0.071
24h Volume:
7,705
Relative Volume:
0.25
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
$-13.56M
P/E Ratio:
-0.00615
EPS:
-11.31
Net Cash Flow:
$-6.30M
1W Performance:
+6.92%
1M Performance:
+25.91%
6M Performance:
-99.72%
1Y Performance:
-99.85%
1-Day Range:
$0.0622
$0.0722
1-Week Range:
$0.0622
$0.0722
52-Week Range:
$0.046
$0.10
Hepion Pharmaceuticals Inc Stock (HEPA) Company Profile
Name
Hepion Pharmaceuticals Inc
Sector
Industry
Phone
-
Address
-
Compare HEPA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HEPA
Hepion Pharmaceuticals Inc
|
0.0695 | 0 | 0 | -13.56M | -6.30M | -11.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Hepion Pharmaceuticals Inc Stock (HEPA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-20-20 | Resumed | ROTH Capital | Buy |
Hepion Pharmaceuticals Inc Stock (HEPA) Latest News
Applying Elliott Wave Theory to Hepion Pharmaceuticals Inc.July 2025 Retail & Free High Return Stock Watch Alerts - newser.com
Order flow analysis tools used on Hepion Pharmaceuticals Inc.Weekly Trend Report & AI Forecasted Stock Moves - newser.com
How Hepion Pharmaceuticals Inc. (336) stock valuation compares with sectorJuly 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - newser.com
Does Hepion Pharmaceuticals Inc. show high probability of rebound2025 Stock Rankings & Free AI Powered Buy and Sell Recommendations - newser.com
Will Hepion Pharmaceuticals Inc. stock gain from strong economyVolume Spike & Long-Term Safe Investment Plans - newser.com
Has Hepion Pharmaceuticals Inc. formed a bullish divergenceWeekly Stock Summary & Community Driven Trade Alerts - newser.com
Will Hepion Pharmaceuticals Inc. stock go up soonJuly 2025 Catalysts & Growth Focused Entry Point Reports - newser.com
Is Hepion Pharmaceuticals Inc. (336) stock resilient in recession scenariosCPI Data & Accurate Technical Buy Alerts - newser.com
Is Hepion Pharmaceuticals Inc. stock a safe investment in uncertain markets2025 Investor Takeaways & Reliable Volume Spike Alerts - newser.com
Will Hepion Pharmaceuticals Inc. (336) stock outperform foreign stocksWeekly Market Outlook & Weekly High Return Stock Forecasts - newser.com
Will Hepion Pharmaceuticals Inc. (336) stock benefit from infrastructure billWeekly Trend Summary & Risk Controlled Daily Trade Plans - newser.com
Published on: 2025-11-02 22:32:49 - newser.com
Published on: 2025-11-02 21:15:57 - newser.com
What moving averages say about Hepion Pharmaceuticals Inc.Quarterly Profit Summary & High Win Rate Trade Tips - newser.com
Trend analysis for Hepion Pharmaceuticals Inc. this weekIndex Update & Risk Controlled Swing Trade Alerts - newser.com
How sustainable is Hepion Pharmaceuticals Inc. stock dividend payoutSell Signal & High Yield Stock Recommendations - newser.com
Is Hepion Pharmaceuticals Inc. stock supported by strong cash flowsWeekly Trade Summary & Daily Chart Pattern Signals - newser.com
Using portfolio simulators with Hepion Pharmaceuticals Inc. included2025 Volatility Report & AI Powered Buy/Sell Recommendations - newser.com
Price action breakdown for Hepion Pharmaceuticals Inc.Weekly Market Report & Community Consensus Picks - newser.com
Why Hepion Pharmaceuticals Inc. stock could be next big winnerJuly 2025 Final Week & Risk Adjusted Buy and Sell Alerts - newser.com
Has Hepion Pharmaceuticals Inc. found a price floorJuly 2025 Sector Moves & Stepwise Trade Execution Plans - newser.com
Hepion Pharmaceuticals Inc Stock (HEPA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.45%
0.86%
Cap:
|
Volume (24h):